SCHEMBL7215528

SCHEMBL7215528

CC(Nc1nc(-c2ccc3ccccc3c2)cn1C)c1ccc(Cl)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATP1A1 P05023 2/20 0.41
ATP1B1 P05026 2/20 0.41
ATP1A3 P13637 2/20 0.41
ATP1B2 P14415 2/20 0.41
ATP1A2 P50993 2/20 0.41
ATP1B3 P54709 2/20 0.41
FXYD2 P54710 2/20 0.41
ATP1A4 Q13733 2/20 0.41
TP53 P04637 2/20 0.36
HTT P42858 2/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
PPARG P37231 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
HSD11B1 P28845 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
PIK3CD O00329 1/20 0.34
CYP2A6 P11509 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7215736 0.86 ATP1A1 (0.36) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL7216143 0.85 ATP1A1 (0.51) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL7216336 0.77 LMNA (0.45) TP53HTTGAAMAPTNPSR1
SCHEMBL7217988 0.76 ATP1A1 (0.51) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL7221640 0.76 ATP1A1 (0.50) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL7222413 0.73 SMN1; SMN2 (0.49) TP53HTTMAPTNPSR1MEN1
SCHEMBL7216242 0.68 ATP1A1 (0.70) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL7229228 0.68 RAB9A (0.55) MAPTNPSR1MEN1KMT2APOLB
SCHEMBL7222472 0.67 PSEN1 (0.39) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL7215522 0.65 SOS1 (0.37) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596739-B2 Anticarcinogenic agents, cardiovascular disorders and antiinflammatory agents THE PROCTER & GAMBLE COMPANY 2003-07-22 US claimed